Jeff Hansen
| This email address is being protected from spambots. You need JavaScript enabled to view it.Research Editor
jeffhans@uab.edu • (205) 209-2355Communicates UAB research discoveries and initiatives from across the university for a variety of audiences.
Specific beats include: biochemistry; cell, developmental and integrated biology; microbiology; molecular genetics; neurobiology; pathology; pharmacology and tocixology; Alabama Drug Discovery Alliance; Bill L. Harbert Institute for Innovation and Entrepreneurship.
A key role for microRNA-155 in brain inflammation and neurodegeneration makes it both a potential therapeutic target and a biomarker for this progressive disorder.
UAB researchers probe basic molecular mechanisms that lead to the lung scarring of pulmonary fibrosis, a lethal disorder.
Measure of Mpl gene expression reveals a heterogonous population of leukemia stem cells: one group leukemic and the other group non-leukemic.
The properties of cubic or spherical shape and solid or elastic stiffness affect the fates of polymer microcapsules meant to carry chemotherapy to a tumor.
One major goal is the discovery of new genotype/phenotype correlations — how a particular mutation indicates that some symptoms in patients are unlikely to develop with age.
The Sickle Cell Foundation has completed a $1 million gift to the UAB Adult Sickle Cell Clinic.
UAB researchers find that epigenetic changes associated with chronic obesity alter expression of memory-related genes in the brain.
Recognition of a new pathway may change the treatment of allergic diseases.
Kearney was cited for outstanding contributions to B cell biology.
UAB-led research shows how methylating an RNA binding protein leads to alternative RNA splicing. Mutant enzymes are often found in blood cancers.